Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 267 followers

Latest posts

Last updated about 8 hours ago

Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Date of authorisation: 26/09/2017, Revision: 16, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Date...

Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation: 12/11/2021, Revision: 8, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation...

Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation: 16/01/2009, Revision: 47, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Date of authorisation...

Human medicines European public assessment report (EPAR): MabThera, rituximab, Date of authorisation: 02/06/1998, Revision: 63, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): MabThera, rituximab, Date of authorisation...

Human medicines European public assessment report (EPAR): Jinarc, tolvaptan, Date of authorisation: 27/05/2015, Revision: 23, Status: Authorised

about 9 hours ago

Human medicines European public assessment report (EPAR): Jinarc, tolvaptan, Date of authorisation...

Human medicines European public assessment report (EPAR): Seffalair Spiromax, salmeterol,fluticasone propionate, Date of authorisation: 26/03/2021, Revision: 2, Status: Authorised

about 9 hours ago

Human medicines European public assessment report (EPAR): Seffalair Spiromax, salmeterol,fluticasone propionate, Date...

Human medicines European public assessment report (EPAR): ellaOne, ulipristal acetate, Date of authorisation: 15/05/2009, Revision: 35, Status: Authorised

about 9 hours ago

Human medicines European public assessment report (EPAR): ellaOne, ulipristal acetate, Date of...

Antimicrobial Sales and Use (ASU) Platform: Release notes

about 9 hours ago

Antimicrobial Sales and Use (ASU) Platform: Release notes

Human medicines European public assessment report (EPAR): Camcevi, leuprorelin, Date of authorisation: 24/05/2022, Revision: 5, Status: Authorised

about 9 hours ago

Human medicines European public assessment report (EPAR): Camcevi, leuprorelin, Date of authorisation...

Human medicines European public assessment report (EPAR): Tukysa, tucatinib, Date of authorisation: 11/02/2021, Revision: 9, Status: Authorised

about 10 hours ago

Human medicines European public assessment report (EPAR): Tukysa, tucatinib, Date of authorisation...

Real-world evidence

about 10 hours ago

Real-world evidence

Reflection paper on use of real-world data in non-interventional studies to generate real-world evidence for regulatory purposes

about 10 hours ago

Reflection paper on use of real-world data in non-interventional studies to generate...